Furthermore, by using S100A9 knockout transgenic mice, which have an impaired MDSC response to cancer, it has been observed a significant delay in tumor growth, which was reverted by adoptive administration of MDSCs, thus evidencing the key role played by MDSCs in tumor escape from immune system. Here, S100A9 is linked to neoplasm.